Logo-bi
Original Research
Balal Khalilzadeh, Nasrin Shadjou, Hadi Afsharan, Morteza Eskandani, Hojjatollah Nozad Charoudeh, Mohammad-Reza Rashidi*
Bioimpacts. 2016;6(3): 135-147. doi: 10.15171/bi.2016.20
PMCID: PMC5108986     PMID: 27853677     Scopus ID: 85004011411    
Original Research
Tatiana Matvienko, Viktoriya Sokolova, Svitlana Prylutska, Yuliia Harahuts, Nataliya Kutsevol, Viktor Kostjukov, Maxim Evstigneev* ORCID, Yuriy Prylutskyy*, Matthias Epple, Uwe Ritter
Bioimpacts. 2019;9(1): 57-63. doi: 10.15171/bi.2019.07
PMCID: PMC6378100     PMID: 30788260     Scopus ID: 85060451771    
It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells, whereas the SWCNT+Dox and GO+Dox nanofluids protected cells from Dox.
Original Research
Zahra Karimzadeh, Siamak Javanbakht, Hassan Namazi*
Bioimpacts. 2019;9(1): 5-13. doi: 10.15171/bi.2019.02
PMCID: PMC6378098     PMID: 30788255     Scopus ID: 85060437287    
Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite was synthesized through a solvothermal technique, which it could encapsulate tetracycline. The drug release tests showed the stability of drug dosing in the gastrointestinal tract conditions. Antibacterial tests exhibited suitable activity to negatively charge E. coli bacteria.
Original Research
Maryam Sadat Khoramgah ORCID, Hossein Ghanbarian, Javad Ranjbari, Nilufar Ebrahimi, Fatemeh Sadat Tabatabaei Mirakabad, Navid Ahmady Roozbahany, Hojjat Allah Abbaszadeh* ORCID, Simzar Hosseinzadeh* ORCID
Bioimpacts. 2023;13(1): 31-42. doi: 10.34172/bi.2021.23711
PMCID: PMC9923815     PMID: 3681700     Scopus ID: 85151746493    
PTFE/PVA/GO/ADSCs construct has a promising result in in-vivo bone regeneration and could be used for large animal models and subsequently for clinical usage.
Original Article
Azadeh Babaei ORCID, Taki Tiraihi* ORCID, Jajar Ai ORCID, Nafiseh Baheiraei ORCID
Bioimpacts. 2023;13(6): 475-487. doi: 10.34172/bi.2023.24266
PMCID: PMC10676529     PMID: 38022379     Scopus ID: 85172790612    


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge